IBDEI2M0 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41673,0)
;;=I25.111^^155^2062^7
;;^UTILITY(U,$J,358.3,41673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41673,1,3,0)
;;=3^Athscl hrt disease of native cor art w ang pctrs w spasm
;;^UTILITY(U,$J,358.3,41673,1,4,0)
;;=4^I25.111
;;^UTILITY(U,$J,358.3,41673,2)
;;=^5007109
;;^UTILITY(U,$J,358.3,41674,0)
;;=I25.118^^155^2062^8
;;^UTILITY(U,$J,358.3,41674,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41674,1,3,0)
;;=3^Athscl hrt disease of native cor art w oth ang pctrs
;;^UTILITY(U,$J,358.3,41674,1,4,0)
;;=4^I25.118
;;^UTILITY(U,$J,358.3,41674,2)
;;=^5007110
;;^UTILITY(U,$J,358.3,41675,0)
;;=I25.119^^155^2062^9
;;^UTILITY(U,$J,358.3,41675,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41675,1,3,0)
;;=3^Athscl hrt disease of native cor art w unsp ang pctrs
;;^UTILITY(U,$J,358.3,41675,1,4,0)
;;=4^I25.119
;;^UTILITY(U,$J,358.3,41675,2)
;;=^5007111
;;^UTILITY(U,$J,358.3,41676,0)
;;=I25.110^^155^2062^10
;;^UTILITY(U,$J,358.3,41676,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41676,1,3,0)
;;=3^Athscl hrt disease of native cor art w unstable ang pctrs
;;^UTILITY(U,$J,358.3,41676,1,4,0)
;;=4^I25.110
;;^UTILITY(U,$J,358.3,41676,2)
;;=^5007108
;;^UTILITY(U,$J,358.3,41677,0)
;;=I25.10^^155^2062^11
;;^UTILITY(U,$J,358.3,41677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41677,1,3,0)
;;=3^Athscl hrt disease of native cor art w/o ang pctrs
;;^UTILITY(U,$J,358.3,41677,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,41677,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,41678,0)
;;=I48.0^^155^2062^28
;;^UTILITY(U,$J,358.3,41678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41678,1,3,0)
;;=3^Paroxysmal atrial fibrillation
;;^UTILITY(U,$J,358.3,41678,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,41678,2)
;;=^90473
;;^UTILITY(U,$J,358.3,41679,0)
;;=I42.9^^155^2062^13
;;^UTILITY(U,$J,358.3,41679,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41679,1,3,0)
;;=3^Cardiomyopathy, unspecified
;;^UTILITY(U,$J,358.3,41679,1,4,0)
;;=4^I42.9
;;^UTILITY(U,$J,358.3,41679,2)
;;=^5007200
;;^UTILITY(U,$J,358.3,41680,0)
;;=I50.42^^155^2062^14
;;^UTILITY(U,$J,358.3,41680,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41680,1,3,0)
;;=3^Chronic combined systolic and diastolic hrt fail
;;^UTILITY(U,$J,358.3,41680,1,4,0)
;;=4^I50.42
;;^UTILITY(U,$J,358.3,41680,2)
;;=^5007249
;;^UTILITY(U,$J,358.3,41681,0)
;;=I50.32^^155^2062^15
;;^UTILITY(U,$J,358.3,41681,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41681,1,3,0)
;;=3^Chronic diastolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,41681,1,4,0)
;;=4^I50.32
;;^UTILITY(U,$J,358.3,41681,2)
;;=^5007245
;;^UTILITY(U,$J,358.3,41682,0)
;;=J44.1^^155^2062^16
;;^UTILITY(U,$J,358.3,41682,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41682,1,3,0)
;;=3^Chronic obstructive pulmonary disease w (acute) exacerbation
;;^UTILITY(U,$J,358.3,41682,1,4,0)
;;=4^J44.1
;;^UTILITY(U,$J,358.3,41682,2)
;;=^5008240
;;^UTILITY(U,$J,358.3,41683,0)
;;=J44.9^^155^2062^17
;;^UTILITY(U,$J,358.3,41683,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41683,1,3,0)
;;=3^Chronic obstructive pulmonary disease, unspecified
;;^UTILITY(U,$J,358.3,41683,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,41683,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,41684,0)
;;=I50.22^^155^2062^18
;;^UTILITY(U,$J,358.3,41684,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41684,1,3,0)
;;=3^Chronic systolic (congestive) heart failure
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2M0 3783 printed Nov 22, 2024@17:41:31 Page 2
IBDEI2M0 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41673,0)
+2 ;;=I25.111^^155^2062^7
+3 ;;^UTILITY(U,$J,358.3,41673,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,41673,1,3,0)
+6 ;;=3^Athscl hrt disease of native cor art w ang pctrs w spasm
+7 ;;^UTILITY(U,$J,358.3,41673,1,4,0)
+8 ;;=4^I25.111
+9 ;;^UTILITY(U,$J,358.3,41673,2)
+10 ;;=^5007109
+11 ;;^UTILITY(U,$J,358.3,41674,0)
+12 ;;=I25.118^^155^2062^8
+13 ;;^UTILITY(U,$J,358.3,41674,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,41674,1,3,0)
+16 ;;=3^Athscl hrt disease of native cor art w oth ang pctrs
+17 ;;^UTILITY(U,$J,358.3,41674,1,4,0)
+18 ;;=4^I25.118
+19 ;;^UTILITY(U,$J,358.3,41674,2)
+20 ;;=^5007110
+21 ;;^UTILITY(U,$J,358.3,41675,0)
+22 ;;=I25.119^^155^2062^9
+23 ;;^UTILITY(U,$J,358.3,41675,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,41675,1,3,0)
+26 ;;=3^Athscl hrt disease of native cor art w unsp ang pctrs
+27 ;;^UTILITY(U,$J,358.3,41675,1,4,0)
+28 ;;=4^I25.119
+29 ;;^UTILITY(U,$J,358.3,41675,2)
+30 ;;=^5007111
+31 ;;^UTILITY(U,$J,358.3,41676,0)
+32 ;;=I25.110^^155^2062^10
+33 ;;^UTILITY(U,$J,358.3,41676,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,41676,1,3,0)
+36 ;;=3^Athscl hrt disease of native cor art w unstable ang pctrs
+37 ;;^UTILITY(U,$J,358.3,41676,1,4,0)
+38 ;;=4^I25.110
+39 ;;^UTILITY(U,$J,358.3,41676,2)
+40 ;;=^5007108
+41 ;;^UTILITY(U,$J,358.3,41677,0)
+42 ;;=I25.10^^155^2062^11
+43 ;;^UTILITY(U,$J,358.3,41677,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,41677,1,3,0)
+46 ;;=3^Athscl hrt disease of native cor art w/o ang pctrs
+47 ;;^UTILITY(U,$J,358.3,41677,1,4,0)
+48 ;;=4^I25.10
+49 ;;^UTILITY(U,$J,358.3,41677,2)
+50 ;;=^5007107
+51 ;;^UTILITY(U,$J,358.3,41678,0)
+52 ;;=I48.0^^155^2062^28
+53 ;;^UTILITY(U,$J,358.3,41678,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,41678,1,3,0)
+56 ;;=3^Paroxysmal atrial fibrillation
+57 ;;^UTILITY(U,$J,358.3,41678,1,4,0)
+58 ;;=4^I48.0
+59 ;;^UTILITY(U,$J,358.3,41678,2)
+60 ;;=^90473
+61 ;;^UTILITY(U,$J,358.3,41679,0)
+62 ;;=I42.9^^155^2062^13
+63 ;;^UTILITY(U,$J,358.3,41679,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,41679,1,3,0)
+66 ;;=3^Cardiomyopathy, unspecified
+67 ;;^UTILITY(U,$J,358.3,41679,1,4,0)
+68 ;;=4^I42.9
+69 ;;^UTILITY(U,$J,358.3,41679,2)
+70 ;;=^5007200
+71 ;;^UTILITY(U,$J,358.3,41680,0)
+72 ;;=I50.42^^155^2062^14
+73 ;;^UTILITY(U,$J,358.3,41680,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,41680,1,3,0)
+76 ;;=3^Chronic combined systolic and diastolic hrt fail
+77 ;;^UTILITY(U,$J,358.3,41680,1,4,0)
+78 ;;=4^I50.42
+79 ;;^UTILITY(U,$J,358.3,41680,2)
+80 ;;=^5007249
+81 ;;^UTILITY(U,$J,358.3,41681,0)
+82 ;;=I50.32^^155^2062^15
+83 ;;^UTILITY(U,$J,358.3,41681,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,41681,1,3,0)
+86 ;;=3^Chronic diastolic (congestive) heart failure
+87 ;;^UTILITY(U,$J,358.3,41681,1,4,0)
+88 ;;=4^I50.32
+89 ;;^UTILITY(U,$J,358.3,41681,2)
+90 ;;=^5007245
+91 ;;^UTILITY(U,$J,358.3,41682,0)
+92 ;;=J44.1^^155^2062^16
+93 ;;^UTILITY(U,$J,358.3,41682,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,41682,1,3,0)
+96 ;;=3^Chronic obstructive pulmonary disease w (acute) exacerbation
+97 ;;^UTILITY(U,$J,358.3,41682,1,4,0)
+98 ;;=4^J44.1
+99 ;;^UTILITY(U,$J,358.3,41682,2)
+100 ;;=^5008240
+101 ;;^UTILITY(U,$J,358.3,41683,0)
+102 ;;=J44.9^^155^2062^17
+103 ;;^UTILITY(U,$J,358.3,41683,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,41683,1,3,0)
+106 ;;=3^Chronic obstructive pulmonary disease, unspecified
+107 ;;^UTILITY(U,$J,358.3,41683,1,4,0)
+108 ;;=4^J44.9
+109 ;;^UTILITY(U,$J,358.3,41683,2)
+110 ;;=^5008241
+111 ;;^UTILITY(U,$J,358.3,41684,0)
+112 ;;=I50.22^^155^2062^18
+113 ;;^UTILITY(U,$J,358.3,41684,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,41684,1,3,0)
+116 ;;=3^Chronic systolic (congestive) heart failure
